Shahed N Badiyan
Overview
Explore the profile of Shahed N Badiyan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
784
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Forghani F, Ginn J, Schiff J, Zhu T, Marut L, Laugeman E, et al.
Radiother Oncol
. 2023 Mar;
182:109603.
PMID: 36889595
Introduction: We aimed to develop knowledge-based tools for robust adaptive radiotherapy (ART) planning to determine on-table adaptive DVH metric variations or planning process errors for stereotactic pancreatic ART. We developed...
12.
Chin R, Schiff J, Shetty A, Pedersen K, Aranha O, Huang Y, et al.
Dis Colon Rectum
. 2023 Mar;
66(7):973-982.
PMID: 36876988
Background: Short-course radiation therapy and consolidation chemotherapy with nonoperative intent has emerged as a novel treatment paradigm for patients with rectal cancer, but there are no data on the predictors...
13.
Schiff J, Maraghechi B, Chin R, Price A, Laugeman E, Rudra S, et al.
Clin Transl Radiat Oncol
. 2023 Jan;
39:100561.
PMID: 36594078
We conducted a prospective pilot study evaluating the feasibility of same day MRI-only simulation and treatment with MRI-guided adaptive palliative radiotherapy (MAP-RT) for urgent palliative indications (NCT#03824366). All (16/16) patients...
14.
Kim M, Schiff J, Price A, Laugeman E, Samson P, Kim H, et al.
Radiat Oncol
. 2022 Sep;
17(1):157.
PMID: 36100866
Background: Online adaptive stereotactic radiotherapy allows for improved target and organ at risk (OAR) delineation and inter-fraction motion management via daily adaptive planning. The use of adaptive SBRT for the...
15.
Badiyan S, Puckett L, Vlacich G, Schiffer W, Pedersen L, Mitchell J, et al.
Curr Treat Options Oncol
. 2022 Sep;
23(10):1388-1404.
PMID: 36087234
Several seminal papers over the last decade have furthered our recognition of radiation-induced heart disease (RIHD) as an important potential toxicity following radiation therapy (RT) to the chest. Investigators continue...
16.
Schiff J, Price A, Stowe H, Laugeman E, Chin R, Hatscher C, et al.
Radiother Oncol
. 2022 Sep;
175:144-151.
PMID: 36063981
Background And Purpose: We conducted a prospective, in silico imaging clinical trial to evaluate the feasibility and potential dosimetric benefits of computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR) for the treatment...
17.
Chin R, Bommireddy A, Fraum T, Ludwig D, Huang Y, Zoberi J, et al.
Adv Radiat Oncol
. 2022 Jul;
7(4):100948.
PMID: 35814852
Purpose: Yttrium-90 (90Y) radioembolization with an escalated dose has been shown to improve clinical outcomes compared with standard dose radioembolization, but there are few data on the local control of...
18.
Schiff J, Stowe H, Price A, Laugeman E, Hatscher C, Hugo G, et al.
Int J Radiat Oncol Biol Phys
. 2022 Jun;
114(5):1022-1031.
PMID: 35768023
Purpose: We conducted a prospective, in silico clinical imaging study (NCT04008537) to evaluate the feasibility of cone beam computed tomography-guided stereotactic adaptive radiation therapy (CT-STAR) for the treatment of abdominal...
19.
Schiff J, Chin R, Roy A, Mahapatra L, Stowe H, Andruska N, et al.
Pract Radiat Oncol
. 2022 May;
12(5):e406-e414.
PMID: 35526826
Purpose: Nonoperative management with short-course radiation therapy (SCRT) as a component of definitive therapy for oligometastatic rectal cancer has not been previously reported. This single-institution retrospective analysis evaluates treatment with...
20.
Chin R, Otegbeye E, Kang K, Chang S, McHenry S, Roy A, et al.
JAMA Netw Open
. 2022 Feb;
5(2):e2146312.
PMID: 35103791
Importance: Short-course radiotherapy and total neoadjuvant therapy (SCRT-TNT) followed by total mesorectal excision (TME) has emerged as a new treatment paradigm for patients with locally advanced rectal adenocarcinoma. However, the...